Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 11 July 2003:
Vol. 301. no. 5630, pp. 218 - 221
DOI: 10.1126/science.1084183
Prev | Table of Contents | Next

Reports

Modulation of {alpha}-Thrombin Function by Distinct Interactions with Platelet Glycoprotein Ib{alpha}

Reha Celikel,1 Richard A. McClintock,1 James R. Roberts,1 G. Loredana Mendolicchio,1 Jerry Ware,1 Kottayil I. Varughese,2* Zaverio M. Ruggeri1*

Thrombin bound to platelets contributes to stop bleeding and, in pathological conditions, may cause vascular thrombosis. We have determined the structure of platelet glycoprotein Ib{alpha} (GpIb{alpha}) bound to thrombin at 2.3 angstrom resolution and defined two sites in GpIb{alpha} that bind to exosite II and exosite I of two distinct {alpha}-thrombin molecules, respectively. GpIb{alpha} occupancy may be sequential, as the site binding to {alpha}-thrombin exosite I appears to be cryptic in the unoccupied receptor but exposed when a first thrombin molecule is bound through exosite II. These interactions may modulate {alpha}-thrombin function by mediating GpIb{alpha} clustering and cleavage of protease-activated receptors, which promote platelet activation, while limiting fibrinogen clotting through blockade of exosite I.

1 Roon Research Center for Arteriosclerosis and Thrombosis, Division of Experimental Thrombosis and Hemostasis; 2 Division of Cellular Biology, Department of Molecular and Experimental Medicine, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.

* To whom correspondence should be addressed. E-mail: ruggeri{at}scripps.edu (Z.M.R.) and kiv{at}scripps.edu (K.I.V.)

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Molecular Basis of the Interactions of the Nogo-66 Receptor and Its Homolog NgR2 with Myelin-Associated Glycoprotein: Development of NgROMNI-Fc, a Novel Antagonist of CNS Myelin Inhibition.
L. A. Robak, K. Venkatesh, H. Lee, S. J. Raiker, Y. Duan, J. Lee-Osbourne, T. Hofer, R. G. Mage, C. Rader, and R. J. Giger (2009)
J. Neurosci. 29, 5768-5783
   Abstract »    Full Text »    PDF »
Platelet receptors and signaling in the dynamics of thrombus formation.
J. Rivera, M. L. Lozano, L. Navarro-Nunez, and V. Vicente (2009)
Haematologica 94, 700-711
   Abstract »    Full Text »    PDF »
Crystal structure of an RNA aptamer bound to thrombin.
S. B. Long, M. B. Long, R. R. White, and B. A. Sullenger (2008)
RNA 14, 2504-2512
   Abstract »    Full Text »    PDF »
Fibrinogen-elongated {gamma} Chain Inhibits Thrombin-induced Platelet Response, Hindering the Interaction with Different Receptors.
S. Lancellotti, S. Rutella, V. De Filippis, N. Pozzi, B. Rocca, and R. De Cristofaro (2008)
J. Biol. Chem. 283, 30193-30204
   Abstract »    Full Text »    PDF »
New Direction for WE Thrombin.
M. C. Berndt and R. K. Andrews (2008)
Arterioscler. Thromb. Vasc. Biol. 28, 205-207
   Full Text »    PDF »
Bivalent Binding to {gamma}A/{gamma}'-Fibrin Engages Both Exosites of Thrombin and Protects It from Inhibition by the Antithrombin-Heparin Complex.
J. C. Fredenburgh, A. R. Stafford, B. A. Leslie, and J. I. Weitz (2008)
J. Biol. Chem. 283, 2470-2477
   Abstract »    Full Text »    PDF »
Thrombin Mutant W215A/E217A Acts as a Platelet GPIb Antagonist.
M. A. Berny, T. C. White, E. I. Tucker, L. A. Bush-Pelc, E. Di Cera, A. Gruber, and O. J.T. McCarty (2008)
Arterioscler. Thromb. Vasc. Biol. 28, 329-334
   Abstract »    Full Text »    PDF »
Platelet Receptor Proteolysis: A Mechanism for Downregulating Platelet Reactivity.
R. K. Andrews, D. Karunakaran, E. E. Gardiner, and M. C. Berndt (2007)
Arterioscler. Thromb. Vasc. Biol. 27, 1511-1520
   Abstract »    Full Text »    PDF »
Thrombin-Cofactor Interactions: Structural Insights Into Regulatory Mechanisms.
T. E. Adams and J. A. Huntington (2006)
Arterioscler. Thromb. Vasc. Biol. 26, 1738-1745
   Abstract »    Full Text »    PDF »
Two-Phase Antithrombotic Protection After Anti-Glycoprotein VI Treatment in Mice.
V. Schulte, H. P. Reusch, M. Pozgajova, D. Varga-Szabo, C. Gachet, and B. Nieswandt (2006)
Arterioscler. Thromb. Vasc. Biol. 26, 1640-1647
   Abstract »    Full Text »    PDF »
Glycoprotein Ib{alpha}-Mediated Platelet Adhesion and Aggregation to Immobilized Thrombin Under Conditions of Flow.
C. Weeterings, J. Adelmeijer, T. Myles, P. G. de Groot, and T. Lisman (2006)
Arterioscler. Thromb. Vasc. Biol. 26, 670-675
   Abstract »    Full Text »    PDF »
The structure of the GPIb-filamin A complex.
F. Nakamura, R. Pudas, O. Heikkinen, P. Permi, I. Kilpelainen, A. D. Munday, J. H. Hartwig, T. P. Stossel, and J. Ylanne (2006)
Blood 107, 1925-1932
   Abstract »    Full Text »    PDF »
Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage.
J. Kisucka, C. E. Butterfield, D. G. Duda, S. C. Eichenberger, S. Saffaripour, J. Ware, Z. M. Ruggeri, R. K. Jain, J. Folkman, and D. D. Wagner (2006)
PNAS 103, 855-860
   Abstract »    Full Text »    PDF »
Directing thrombin.
D. A. Lane, H. Philippou, and J. A. Huntington (2005)
Blood 106, 2605-2612
   Abstract »    Full Text »    PDF »
The {alpha}1 helix-{beta}13 strand spanning Leu214 to Val229 of platelet glycoprotein Ib{alpha} facilitates the interaction with von Willebrand factor: evidence from characterization of the epitope of monoclonal antibody AP1.
Y. Peng, M. C. Berndt, M. A. Cruz, and J. A. Lopez (2004)
Blood 104, 3971-3978
   Abstract »    Full Text »    PDF »
Factor XI Interacts with the Leucine-rich Repeats of Glycoprotein Ib{alpha} on the Activated Platelet.
F. A. Baglia, C. N. Shrimpton, J. Emsley, K. Kitagawa, Z. M. Ruggeri, J. A. Lopez, and P. N. Walsh (2004)
J. Biol. Chem. 279, 49323-49329
   Abstract »    Full Text »    PDF »
Crystal Structure of the Wild-type von Willebrand Factor A1-Glycoprotein Ib{alpha} Complex Reveals Conformation Differences with a Complex Bearing von Willebrand Disease Mutations.
J. J. Dumas, R. Kumar, T. McDonagh, F. Sullivan, M. L. Stahl, W. S. Somers, and L. Mosyak (2004)
J. Biol. Chem. 279, 23327-23334
   Abstract »    Full Text »    PDF »
GPIb-dependent platelet activation is dependent on Src kinases but not MAP kinase or cGMP-dependent kinase.
S. J. Marshall, Y. A. Senis, J. M. Auger, R. Feil, F. Hofmann, G. Salmon, J. T. Peterson, F. Burslem, and S. P. Watson (2004)
Blood 103, 2601-2609
   Abstract »    Full Text »    PDF »
Effects of Thrombin on Interactions Between {beta}3-Integrins and Extracellular Matrix in Platelets and Vascular Cells.
G.A. Stouffer and S.S. Smyth (2003)
Arterioscler. Thromb. Vasc. Biol. 23, 1971-1978
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)